3 A-Rated Biotech Stocks for Your 2024 Portfolio

With the rising prevalence of chronic diseases worldwide, favorable government measures, and the growing adoption of AI in healthcare, demand for innovative drugs and treatments has been rising considerably, boosting the biotech industry’s outlook. Given the industry’s steady growth prospects, investors could buy A-rated biotech stocks Entrada Therapeutics, Inc. (TRDA – Get Rating), Corcept Therapeutics Incorporated (CORT – Get […] December 14, 2023 [Option Sensei] [3 A-Rated Biotech Stocks for Your 2024 Portfolio]( With the rising prevalence of chronic diseases worldwide, favorable government measures, and the growing adoption of AI in healthcare, demand for innovative drugs and treatments has been rising considerably, boosting the biotech industry’s outlook. Given the industry’s steady growth prospects, investors could buy A-rated biotech stocks Entrada Therapeutics, Inc. ([TRDA]( – [Get Rating]( Corcept Therapeutics Incorporated ([CORT]( – [Get Rating]( and Alkermes plc ([ALKS]( – [Get Rating]( this year. Growing foothold of personalized medicine and an increasing number of orphan drug formulations are opening new avenues for biotechnology applications and are driving the influx of emerging and innovative biotechnology companies, further boosting the market revenue. The global biotechnology market is expected to grow at a [CAGR of 14%]( until 2030. The Biden-Harris Administration is [implementing new measures to promote healthcare competition]( and lower prescription drug costs for American families. They have released a proposed framework for agencies to exercise march-in rights on taxpayer-funded drugs, ensuring affordability and reasonable availability. Moreover, the growing demand for the discovery and development of novel drug therapies and increasing manufacturing capacities of the life science industry are driving the demand for artificial intelligence (AI) empowered solutions in the drug discovery processes. The global artificial intelligence in drug discovery market is expected to expand at a [CAGR of 29.6%]( until 2030. With these favourable trends in mind, let’s delve into the fundamentals of the three best [Biotech]( stocks, beginning with… Continue reading at [STOCKNEWS.com]( NOTE: If URLs do not appear as live links in your e-mail program, please cut and paste the full URL into the location or address field of your browser. [Privacy Policy]( | [Terms & Conditions]( This is a paid advertisement.This is not a solicitation for the purchase or sale of securities. Readers are encouraged to conduct their own research and due diligence, and/or obtain professional advice, prior to making any investment decision. Advertisements and sponsorships are provided as a service to Wealthpop users. Wealthpop is not responsible for their content, services or products. The statements and opinions contained in this advertisement are not those of Wealthpop, and Wealthpop disclaims any liability for or arising from such statements and opinions. You are hereby advised that Wealthpop is receiving a fee as compensation for the distribution of this advertisement. [Click here to unsubscribe]( Copyright © 2023 Wealthpop. All rights reserved. Magnifi Communities, 1 Penn Plaza, Suite 3910, New York, NY 10019